*The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, NY;
†Department of Psychiatry, University of Lausanne, Prilly-Lausanne, Switzerland;
‡Department of Psychiatry, Central Hospital, Sanitary Agency of South Tyrol, Bolzano, Italy;
§Psychiatric Hospital, Klinikum am Weissenhof, Weinsberg, Germany;
¶Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany;
║Department of Psychiatry and Psychotherapy, University of Frankfurt, Frankfurt, Germany;
**Department of Psychiatry and Psychosomatics, University of Göttingen, Göttingen, Germany;
††Forensic Psychiatric Hospital, Vitos Klinik, Eichberg, Eltville, Germany;
‡‡Psychiatric and Psychotherapeutic Private Clinic Clienia Schlössli, Academic Teaching Hospital of the University of Zurich, Oetwil am See, Switzerland;
§§Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany;
¶¶Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research, National Institutes of Health, Bethesda, MD;
║║Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Munich, Germany;
***Department of Psychiatry, Medical University of Innsbruck, Innsbruck, Austria;
†††Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria; and
‡‡‡Department of Psychiatry and Psychotherapy, Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Mainz, Germany.
Correspondence: Georgios Schoretsanitis, MD, PhD, Zucker Hillside Hospital, Behavioral Health Pavilion, 7559 263rd St, Glen Oaks, NY 11004 (e-mail: [email protected]).
Participated in research design: G. Schoretsanitis, C. Hiemke, and GG. Performed data search and extract: G. Schoretsanitis, P. Baumann, O. Dietmaier, X. Hart, G. Hefner, M. Kuzin, R. Mössner, C. Hiemke, Gerhard Gründer, and P. Baumann. Performed data analysis: G. Schoretsanitis and C. Hiemke. Wrote or contributed to the writing of the article: G. Schoretsanitis, P. Baumann, A. Conca, O. Dietmaier, Giancarlo Giupponi, Gerhard Gründer, M. Hahn, X. Hart, U. Havemann-Reinecke, G. Hefner, M. Kuzin, R. Mössner, D. Piacentino, W. Steimer, G. Zernig, and C. Hiemke.
P. Baumann has received speaker or consultancy fees from almost all pharmaceutical companies selling psychotropic drugs in Switzerland. A. Conca has served as a consultant for Eli Lilly, Bristol-Myers Squibb, and Pfizer. He has served on the speakers' bureau of Eli Lilly, BMS, Astra Zeneca, Lundbeck, Italfarma, and Janssen. U. Havemann-Reinecke has received speaker consultancy and advisory fees and unrestricted educational grants from AstraZeneca, Hexal, Indivior London, Janssen Cilag, Lundbeck, Pfizer, and Sanofi. G. Gründer has served as a consultant for Allergan, Boehringer Ingelheim, Institute for Quality and Efficiency in Health Care (IQWiG), Janssen-Cilag, Lundbeck, Otsuka, Recordati, Sage, and Takeda. He has served on the speakers' bureau of Gedeon Richter, Janssen Cilag, Lundbeck, Otsuka, and Recordati. He has received grant support for conducting clinical trials from Boehringer Ingelheim, Lundbeck, and Saladax. He is the cofounder and shareholder of Mind and Brain Institute GmbH, Brainfoods GmbH, OVID Health Systems GmbH, and MIND Foundation gGmbH. M. Kuzin received travel grants from Sunovion Pharmaceutical (Basel, Switzerland) and Otsuka Pharmaceutical (Glattbrugg, Switzerland). He also received a travel grant, participated, and obtained a grant from the speaker board of Lundbeck (Zurich, Switzerland). G. Zernig has received speaker or consultancy fees or educational grants from AlcaSynn, AstraZeneca, Bio-Rad, Bristol-Myers Squibb, Eli Lilly, Lundbeck, Mundipharma, Novartis, Pfizer, and Wyeth. C. Hiemke has received speaker fees from Otsuka. He is the editor of an internet-based drug–drug interaction program (www.psiac.de). The remaining authors declare no conflict of interest.
